Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Men and Women With Osteoporosis.

Trial Profile

Effect of 24 Months of Teriparatide Therapy on Bone Microarchitecture and Bone Volume in Men and Women With Osteoporosis.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Dec 2016

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 27 Oct 2016 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
    • 27 Oct 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.
    • 09 Jul 2013 Planned end date changed from 1 Jan 2014 to 1 Jan 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top